Intra-Cellular Therapies, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Intra-Cellular Therapies, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2012 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$1.67B, a 5.44% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$1.67B -$86.4M -5.44% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$1.65B -$84.3M -5.39% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$1.63B -$111M -7.29% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1.62B -$140M -9.45% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 -$1.59B -$155M -10.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$1.56B -$184M -13.4% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$1.52B -$228M -17.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$1.48B -$256M -21% Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$1.43B -$298M -26.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$1.38B -$321M -30.4% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$1.29B -$304M -30.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$1.22B -$284M -30.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$1.14B -$259M -29.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$1.06B -$237M -28.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$990M -$232M -30.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$937M -$227M -32% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$876M -$207M -30.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$821M -$187M -29.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$758M -$160M -26.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$710M -$148M -26.3% Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$670M -$148M -28.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$635M -$155M -32.2% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$597M -$154M -34.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$562M -$155M -38.1% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$522M -$145M -38.3% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$480M -$126M -35.6% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 -$443M -$106M -31.6% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 -$407M -$97.8M -31.6% Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$377M -$95M -33.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$354M -$102M -40.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$336M -$116M -52.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$309M -$116M -60.3% Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$282M -$118M -71.7% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$252M -$120M -90.6% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$221M -$110M -99.8% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 -$193M -$105M -119% Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$164M -$91.2M -125% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 -$132M -$65.4M -98.2% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 -$111M -$48.4M -78% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 -$88.3M -$30.7M -53.3% Dec 31, 2014 10-K 2016-02-25
Q3 2014 -$73.1M -$23.5M -47.5% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 -$66.6M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 -$62.1M Mar 31, 2014 10-Q 2014-05-05
Q4 2013 -$57.6M -$26.9M -87.5% Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$49.5M Sep 30, 2013 10-Q 2013-11-05
Q4 2012 -$30.7M Dec 31, 2012 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.